IL17A and breast carcinoma: In breast cancer, we infer that NEFM transcriptional expression may affect survival partially through the decreased M2 macrophage infiltration and anti-tumor cytotoxicity of cytokine–cytokine receptor interaction and IL-17 signaling pathway.